Company: WELNF
Filing Date: 2025-12-04
Form Type: DEFA14A
Source: 0001104659-25-118484
Chunk: 22

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-12-04
Form: DEFA14A
Chunk 22
---
 actual results could differ
significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term
investments with an original maturity of three months or less when purchased to be cash equivalents. The Company does not have any
cash equivalents as of September 30, 2025 or December 31, 2024.

Cash and Marketable Securities Held in Trust Account

Following the closing of the
IPO on December 13, 2021, an amount of $117,300,000 from the net proceeds of the sale of the Units in the IPO and the sale of the
Private Placement Warrants was placed in the Trust Account and invested in money market funds meeting certain conditions under Rule 2a-7
under the Investment Company Act, which invest only in direct U.S. government treasury obligations. The Trust Account is intended as a
holding place for funds pending the earliest to occur of: (i) the completion of a Business Combination and (ii) the distribution
of the funds held in the Trust Account. As of September 30, 2025 and December 31, 2024, substantially all of the assets were held in cash
deposits. Dividend income, if any, is included in other income as earnings on marketable securities held in the Trust Account, interest
income is included in other income as interest earned on cash held in the Trust Account, and accrued dividend income, if any, is included
in other income as unrealized (loss) gain on marketable securities held in the Trust Account in the condensed consolidated statements
of operations.

Derivative Financial Instruments

The Company accounts for derivative
liabilities as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific
terms and applicable authoritative guidance in ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers
whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC
480, and whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments
are indexed to the Company’s own common shares and whether the instrument holders could potentially require “net cash settlement”
in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires
the use of professional judgment, was conducted at the time of issuance and as of each subsequent quarterly period end date while the
instruments are outstanding